augment off-axis instrument system
augment off-axis instrument system: developed by 1 company · 1 FDA decision. Updated within the last hour.
Lead developer: Zimmer Biomet Holdings Inc. (ZBH)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zimmer Biomet Holdings Inc. (ZBH) | — |
FDA Decisions
Frequently asked questions
Who is developing augment off-axis instrument system?
augment off-axis instrument system is being developed by Zimmer Biomet Holdings Inc..
What is augment off-axis instrument system's latest FDA decision?
The most recent tracked FDA decision for augment off-axis instrument system is 510(k) Clearance for Summary, dated June 16, 2026.
Analyze Zimmer Biomet Holdings Inc. & augment off-axis instrument system with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company